You Can Get Mono Twice

Can you get mono twice? Symptoms, Causes & Prevention

Mono is one of those illnesses with an embarrassing reputation. Called “the kissing disease,” mono causes extreme fatigue and can be almost impossible to avoid getting if you come into contact with someone carrying it.

95% of Americans will contract mono during their lifetime. By the age of five, half of children are already affected.

In children, mono is milder and can be mistaken for a cold. In teens and young adults, though, mono may put your life on pause for weeks or months.

So it’s a good thing you can’t get mono twice — right? That is the common thought, but it’s not true.

What are the chances of getting mono twice? It can happen .

The virus that causes infectious mono is called Epstein-Barr virus (also known as human herpesvirus 4), and it remains in your body your whole life. Usually, EBV just lives in your body while your immune system makes sure it isn’t getting up to any trouble. But in some cases, EBV may reactivate causing symptoms and contagiousness again.

EBV is a stealth pathogen. Stealth pathogens lay dormant in your body, only to crop up at a later date and trigger symptoms that can be very hard to identify.

There are methods of preventing stealth pathogens from reactivating. Learn about them — and what mono really is — below.

What causes mono?

Infectious mononucleosis (AKA mono, or glandular fever) is an infectious disease. It’s sometimes called “the kissing disease” because one of the most common ways it spreads is body fluids, such as saliva. However it can also spread through blood transfusions, sexual contact, and organ transplants.

When you have a mono infection, you need plenty of rest. It’s best to avoid heavy lifting and contact sports while you recover, because of an enlargement of the spleen, known as splenomegaly. Visit your healthcare provider for tips on how to best care for yourself and handle the symptoms related to mono.

What causes mono flare ups?

Epstein-Barr virus (EBV) causes mono infections and remains in your body for your whole life. EBV is actually a member of the herpes virus family — EBV is also called human herpesvirus 4.

According to the Centers for Disease Control and Prevention, EBV is one of the most common viruses in the world. Almost 95% of adults are infected.

And it doesn’t just cause mono. It’s estimated that EBV leads to 200,000 new cases of cancer each year . (This is a relatively small amount since more than seven billion people live with EBV.)

EBV induces cancer in a small number of people and is most commonly associated with cancers of the head, neck, and lymphoma. It is currently unclear why this happens in only a small number of people. It will be interesting as the science comes to light and new information develops to see where there are potentially more ties.

EBV can be diagnosed with a blood test that detects elevated white blood cell count or EBV antibodies. About nine in ten adults possess EBV antibodies, showing they either have or at one point had an EBV infection.

However, let me say that testing can be confusing and frustrating. There are a number of tests that can be run, each indicating different stages of EBV. So to cut down on confusion talk with your functional medicine provider about testing.

It’s so easy to spread EBV:

Sharing eating utensils Sharing toothbrushes Close contact with an infected person Exchanging bodily fluids (especially saliva)

Chronic active EBV disease (CAEBV) is a complication of EBV. It is not a simple reactivation, but a chronic continual EBV infection. It’s unclear why a few people with EBV go on to develop chronic EBV, but it might have to do with a weakened immune system. These patients often present similarly to other EBV patients, however, their labs will indicate marked elevation of EBV DNA in the blood and infiltration of organs by EBV-positive lymphocytes.

This form of EBV occurs when patients who have EBV infection are unable to control the infection; the virus remains in an active state, allowing symptoms of EBV infection to persist and progress. These patients can suffer potentially fatal complications and succumb to opportunistic infections, hemophagocytosis, multiorgan failure, or EBV-positive lymphoma related to immunodeficiency if not treated.

What looks like mono, but isn’t?

At this time it’s really unknown how common it is to get mono twice because there isn’t a lot of information or standardized tests yet to understand the virus, it’s possible you have contracted another virus that exhibits similar symptoms. Some other viruses and disorders to consider being checked for:

Influenza is a viral infection in your respiratory system. More commonly known as “the flu,” influenza causes mono-like symptoms, but also runny or stuffy nose, chills, and a cough. Strep throat is a bacterial infection — you guessed it — in your throat. Strep throat triggers some mono-like symptoms, but can also present white patches on your tonsils and red spots in the back of your mouth. If left untreated Strep can lead to complications and development of more serious conditions such as rheumatic fever, scarlet fever, poststreptococcal reactive arthritis, or poststreptococcal glomerulonephritis. If you think you have strep see your provider. Hepatitis A is a highly contagious viral infection of the liver. Hepatitis A exhibits mono-like symptoms although it also exhibits other symptoms such as nausea, vomiting, jaundice, and joint pain. Rubella is a viral infection that shares symptoms with mono. However, rubella has some unique symptoms: facial rash, red eyes, runny nose, and a cough. Myalgic encephalomyelitis (ME) is another disorder often mistaken for mono, and formerly known as chronic fatigue syndrome. This makes sense since the primary symptom in both mono and ME is extreme tiredness. Cytomegalovirus (CMV) is a common virus that can trigger symptoms similar to mono. This virus affects every age group. Although the symptoms between CMV and mono are close, CMV does not result in a sore throat.

Note* that it is statistically less likely you have contracted Coronavirus (COVID 19) , if you are having symptoms of fever, chills, fatigue, and headache (shared symptoms with mono) consider this alternative if you have a cough (dry or sputum producing). You then might want to get screened for COVID 19.

Common Mono Symptoms

Symptoms of infectious mononucleosis usually appear 4-6 weeks after you have caught Epstein-Barr virus infection.

Mono symptoms

Severe fatigue (may persist longer than other symptoms) Severe sore throat Swollen glands in your neck Swollen tonsils Loss of appetite Body aches Fever Headache

Symptoms of chronic EBV

Severe fatigue lasting for multiple months Swollen lymph nodes that persist Enlarged spleen Enlarged liver (possibly liver failure) Anemia Rash Nerve damage Low levels of platelets in your blood Low levels of infection-fighting immune cells

Causes of Recurring Mono

Can you get mono twice? Yes, you can get mono twice. The medical community is just now coming around to the idea that many people don’t get mono just once , and that having the virus can result in issues for decades. Here are some risk factors that increase the likelihood of getting mono twice:

Living in Asia, Mexico, Central America, South America HIV infection Pregnancy Organ transplant Genetic factors Weakened immune system Stress Extreme Fatigue Other illness or anything that stress the body

Your immune system can also be weakened by alcohol, smoking, chronic stress , or poor nutrition , making it easier for mono to recur.

Is mono worse the second time?

No, if mono recurs, it’s often weaker than the first time, however the symptoms can be drastically different and elusive. This is why it's known as a stealth pathogen. Sometimes, the recurring mono will not exhibit any similar symptoms.

Can mono come back with stress?

Chronic stress can weaken your immune system , so it’s possible that this could be one trigger leading to a bout of recurrent mono.

A Whole-Body Approach to Preventing Mono

Preventing mono the first time is almost impossible. 95% of people will contract EBV in their lifetime, which leads to mono.

But you may be able to prevent mono from happening a second time.

EBV is a stealth pathogen. If your immune system remains strong and effective, EBV should should be less likely to give you mono a second time.

What are stealth pathogens? Stealth pathogens are bacteria or viruses that can survive undetected in your body for months or even years before triggering an infection. Usually, stealth pathogens lead to chronic diseases or autoimmune disorders.

This is a controversial topic. As scientific evidence mounts in favor of stealth pathogens’ ability to hide from or suppress your immune system, many doctors are unaware of the research. Because of this, a doctor who doesn’t practice with a functional mindset may not think to investigate stealth pathogens as a cause of your symptoms, or they may simply dismiss you as over reactive and refuse to do testing.

How to treat stealth pathogens like EBV

The best defense against getting mono a second time is making sure your immune system is top notch.

How can you strengthen your immune system?

Don’t smoke Don’t drink excessively Minimize stress Healthy, nutrient rich diet High-quality sleep Exercise regularly Wash hands thoroughly Maintain a healthy weight Consider probiotics, to counteract lack of good bacteria in your gut microbiome Elderberry or vitamin C supplements for shorter bursts of strengthened immunity

NOTE ON ANTIBIOTICS FOR EBV OR MONO: It may be necessary to treat secondary infections related to mono such as streptococcal (strep) infection, sinus infection, or an infection of your tonsils (tonsillitis) with antibiotics (along with antibiofilms). However, antibiotic treatment, while experiencing mono, must be monitored and prescribed with caution.

Taking an antibiotic if you have EBV can result in an itchy rash caused by Amoxicillin and other penicillin derivatives. This rash doesn't mean that they are allergic to the antibiotic — it's an interaction related to EBV.

Conventional medicine would recommend painkillers, such as acetaminophen (Tylenol) or ibuprofen (Advil), to relieve the symptoms of mono. At The Fork, we do not recommend treatments that only mask symptoms while introducing adverse side effects to your body.

If you want to bring down a fever or ease aching, try these all-natural painkillers :

Lavender oil Peppermint oil Ginger Feverfew Curcumin (found in turmeric) Lukewarm bath

Also when we have patients with EBV we recommend rest, self care, and supplements that slow down the replication of the virus, strengthen the immune system, and suppress reactivation.

Monolaurin Viracid Glutathione Silver hydrosol Olive Leaf L-Lysine Licorice Root Extract Selenium and Zinc CoQ10 Vitamins A, C, D3, K2, and the B’s

Talk to your functional medicine provider to find out what's right for you.

Always consult your healthcare provider for medical advice when you take up a new dietary supplement or lifestyle adjustment.

If you live in Middle Tennessee or are willing to travel for quality services, call 615-721-8008 or click here to make an appointment at The Fork Functional Medicine in Franklin, TN. We help patients develop an individualized plan for whole-body health that can prevent stealth pathogens from wreaking their havoc.

Looking to the Future

Mono has affected billions of people in the world. It is possible to get mono twice.

The people who do contract mono a second time may have a weak immune system for one reason or another. Working with a functional medicine provider , you can engage in whole-body health that strengthens your immune response and prevents all sorts of chronic diseases.

Seek medical attention right away if you have difficulty breathing or swallowing, a high fever, debilitating headache, sharp pain on your left side or in your abdomen, or yellow in your eyes — as these are signs of serious conditions needing immediate attention.

Sources

Mohseni, M., Boniface, M. P., & Graham, C. (2019). Mononucleosis. Full text: https://www.ncbi.nlm.nih.gov/books/NBK470387/ Lennon, P., Crotty, M., & Fenton, J. E. (2015, March). Infectious mononucleosis: frequently asked questions. In IRISH JOURNAL OF MEDICAL SCIENCE (Vol. 184, pp. S167-S167). Full text: https://www.bmj.com/bmj/section-pdf/895012?path=/bmj/350/8005/Clinical_Review.full.pdf Rostgaard, K., Balfour Jr, H. H., Jarrett, R., Erikstrup, C., Pedersen, O., Ullum, H., ... & Hjalgrim, H. (2019). Primary Epstein-Barr virus infection with and without infectious mononucleosis. PloS one , 14 (12). Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917282/ Cohen, J. I., Jaffe, E. S., Dale, J. K., Pittaluga, S., Heslop, H. E., Rooney, C. M., ... & Burbelo, P. D. (2011). Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood, The Journal of the American Society of Hematology , 117 (22), 5835-5849. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112034/ Balfour, H. H., Dunmire, S. K., & Hogquist, K. A. (2015). Infectious mononucleosis. Clin. Transl. Immunol. 4 (2), e33. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670567/ Kimura, H., & Cohen, J. I. (2017). Chronic active Epstein–Barr virus disease. Frontiers in immunology , 8 , 1867. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770746/ Sangueza-Acosta, M., & Sandoval-Romero, E. (2018). Epstein-Barr virus and skin. Anais brasileiros de dermatologia , 93 (6), 786-799. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256212/ Yaribeygi, H., Panahi, Y., Sahraei, H., Johnston, T. P., & Sahebkar, A. (2017). The impact of stress on body function: A review. EXCLI journal , 16 , 1057. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579396/ Ben-Tekaya, H., Gorvel, J. P., & Dehio, C. (2013). Bartonella and Brucella—weapons and strategies for stealth attack. Cold Spring Harbor perspectives in medicine , 3 (8), a010231. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721268/ Gao, F., Barchowsky, A., Nemec, A. A., & Fabisiak, J. P. (2004). Microbial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickel. Toxicological Sciences , 81 (2), 467-479. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290844/ Ahn, D., & Prince, A. (2017). Host-pathogen interface: progress in understanding the pathogenesis of infection due to multidrug-resistant bacteria in the intensive care unit. The Journal of infectious diseases , 215 (suppl_1), S1-S8. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853223/ Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018). Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. International journal of environmental research and public health , 15 (5), 1033. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982072/ Barr, T., Helms, C., Grant, K., & Messaoudi, I. (2016). Opposing effects of alcohol on the immune system. Progress in Neuro-Psychopharmacology and Biological Psychiatry , 65 , 242-251. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911891/ Asif, N., Iqbal, R., & Nazir, C. F. (2017). Human immune system during sleep. American journal of clinical and experimental immunology , 6 (6), 92. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768894/ Sasannejad, P., Saeedi, M., Shoeibi, A., Gorji, A., Abbasi, M., & Foroughipour, M. (2012). Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial. European neurology , 67 (5), 288-291. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22517298 Borhani Haghighi, A., Motazedian, S., Rezaii, R., Mohammadi, F., Salarian, L., Pourmokhtari, M., ... & Miri, R. (2010). Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double‐blind, placebo‐controlled, crossed‐over study. International journal of clinical practice , 64 (4), 451-456. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20456191 Martins, L. B., Rodrigues, A. M. D. S., Rodrigues, D. F., dos Santos, L. C., Teixeira, A. L., & Ferreira, A. V. M. (2019). Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) addition in migraine acute treatment. Cephalalgia , 39 (1), 68-76. Moscano, F., Guiducci, M., Maltoni, L., Striano, P., Ledda, M. G., Zoroddu, F., ... & Parisi, P. (2019). An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache. Italian journal of pediatrics , 45 (1), 36. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419324/ Sun, J., Chen, F., Braun, C., Zhou, Y. Q., Rittner, H., Tian, Y. K., ... & Ye, D. W. (2018). Role of curcumin in the management of pathological pain. Phytomedicine , 48 , 129-140. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30195871